| Business Summary | | IMS
Health,
Inc.
is
a
provider
of
information
solutions
to
the
pharmaceutical
and
healthcare
industries.
IMS
Health
operates
in
approximately
100
countries
and
during
2000
consisted
of:
the
IMS
Segment,
a
leading
global
provider
of
market
information,
sales
management
and
decision-support
services
to
the
pharmaceutical
and
healthcare
industries;
the
Cognizant
Technology
Solutions
Segment,
which
delivers
high
quality,
cost-effective,
full
life
cycle
solutions
to
complex
software
development
and
maintenance
problems
that
companies
face
as
they
transition
to
e-business;
and
the
Transaction
Businesses
Segment,
which
includes
Synavant,
Inc.,
Erisco
Managed
Care
Technologies,
Inc.
and
three
small
non-strategic
software
companies. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | IMS
Health,
Inc.
is
a
global
provider
of
information
solutions
to
the
pharmaceutical
and
healthcare
industries,
including
market
information
and
decision-support
services.
For
the
six
months
ended
6/30/01,
operating
revenue
fell
8%
to
$663.9
million.
Net
income
fell
2%
to
$130.4
million.
Revenues
reflect
the
absence
of
Synavant
and
Erisco
revenues
following
their
dispositions.
Earnings
were
partially
offset
by
improved
operating
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| David Thomas, 51 Chairman,
CEO | $2.8M | -- | James Malone, 52 CFO | 1.6M | $2.0M | Gilles Pajot, 51 Exec.
VP, Director | 1.8M | 393K | Robert Steinfeld, 47 Sr.
VP, Gen. Counsel, Sec. | 491K | 398K | Murray Aitken, 42 Sr.
VP of Services and Consulting | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|